Cardiometabolic phenotype and UKPDS risk in male type 2 diabetic patients with obstructive sleep apnoea

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 3, Issue 1, 2009, Pages 50-54

  Hermans, Michel P ^a   Ahn, Sylvie A ^a   Rousseau, Michel F ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cardiometabolic; Obesity; Obstructive sleep apnoea syndrome; Type 2 diabetes; UKPDS Risk Engine

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FATTY LIVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIMETRY; PHENOTYPE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP APNEA SYNDROME; WAIST CIRCUMFERENCE;

EID: 62649100647     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2008.10.011     Document Type: Article

References (29)

1. Meslier N., Gagnadoux F., Giraud P., Person C., Ouksel H., Urban T., et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22 (2003) 156-160
2. Oltmanns K.M., Gehring H., Rudolf S., Schultes B., Rook S., Schweiger U., et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169 (2004) 1231-1237
3. Harsch I.A., Hahn E.G., and Konturek P.C. Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit 11 (2005) 70-75
4. Kaparianos A., Sampsonas F., Karkoulias K., and Spiropoulos K. The metabolic aspects and hormonal derangements in obstructive sleep apnoea syndrome and the role of CPAP therapy. Eur Rev Med Pharmacol Sci 10 (2006) 319-326
5. West S.D., Nicoll D.J., and Stradling J.R. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 61 (2006) 945-950
6. Sadikot S.M. An overview: obstructive sleep apnea and the metabolic syndrome: should "X" be changed to "Zzz ... Zzzz ... Zzzzzzzzz ... Zzz"?. Diab Met Syndr Clin Res Rev 1 (2007) 287-302
7. The IDF Consensus Statement on sleep apnoea and Type 2 diabetes. IDF Communications (Brussels) 2008:1-23 [www.idf.org/].
8. Kiely J.L., and McNicholas W.T. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16 (2000) 128-133
9. Hatipoǧlu U., and Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70 (2003) 665-671
10. Dincer H.E., and O'Neill W. Deleterious effects of sleep-disordered breathing on the heart and vascular system. Respiration 73 (2006) 124-130
11. Peker Y., Carlson J., and Hedner J. Increased incidence of coronary artery disease in slee apnoea: a long-term follow-up. Eur Respir J 28 (2006) 596-602
12. McNicholas W.T., and Bonsigore M.R. Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29 (2007) 156-178
13. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
14. Johns M.W. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 103 (1993) 30-36
15. AASM. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22:667-89.
16. Stevens R.J., Coleman R.L., Adler A.I., Stratton I.M., Matthews D.R., and Holman R.R. UKPDS 66: risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes. Diabetes Care 27 (2004) 201-207
17. Hermans M.P., Ahn S., and Rousseau M.F. Neurohormonal biomarkers and UKPDS stroke risk in type 2 diabetic women on primary cardiovascular prevention. Diab Met Syndr Clin Res Rev 2 (2008) 93-98
18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20, 1183-97.
19. Kyle U.G., Morabia A., Schutz Y., and Pichard C. Sedentarism affects body fat mass index and fat-free mass index in adults aged 18 to 98 years. Nutrition 20 (2004) 255-260
20. Burkhauser R.V., and Cawley J. Beyond BMI: the value of more accurate measures of fatness and obesity in social science research. J Health Econ 27 (2008) 519-529
21. Valdez R., Seidell J.C., Ahn Y.I., and Weiss K.M. A new index of abdominal adiposity as an indicator of risk for cardiovascular disease: a cross-population study. Int J Obes 16 (1992) 77-82
22. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
23. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
24. Hermans M.P., Levy, Morris R.J., and Turner R.C. Comparison of insulin sensitivity tests across a range of glucose tolerance form normal to diabetes. Diabetologia 42 (1999) 678-687
25. Munoko T., and Hermans M.P. Phenotypic characterization of first generation Maghrebian migrants with type 2 diabetes: A gender-based comparison with a reference North-Caucasian Belgian cohort. Diab Met Syndr Clin Res Rev 2 (2008) 115-124
26. Cohen P.G. The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt-a major factor in the genesis of morbid obesity. Med Hypotheses 52 (1999) 49-51
27. Pillar G., and Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg?. Diabetes Care 31 Suppl. 2 (2008) S303-S309
28. Dehout F., Haumont S., Gaham N., Amoussou-Guenou K.D., and Hermans M.P. Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: prevalence, gender differences and HOMA hyperbolic product. Diab Met Syndr Clin Res Rev 2 (2008) 5-11
29. Hermans M.P., Ahn S.A., Gruson D., and Rousseau M.F. The metabolic syndrome phenotype is associated with raised circulating Big endothelin-1 independently of coronary artery disease in type 2 diabetes. Diab Met Syndr Clin Res Rev 1 (2007) 229-237